Efavirenz with emtricitabine and tenofovir disoproxil (Viatris): Supply issue
Viatris advises that it's Viatris brand efavirenz with emtricitabine and tenofovir disoproxil (Pharmacode: 2644967) will be out of stock for the foreseeable future.
On this page
11 June 2026 | New alternative brand funded
A temporary new brand will be funded from 12 June 2026. Stock of the currently supplied brand, Teevir, is likely to run out before the end of June.
Affected product
Viatris advises that there are delays at the manufacturer affecting the following product.
Efavirenz with emtricitabine and tenofovir disoproxil
- Presentation: Tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a maleate)
- Brand: Viatris
- Pharmacode: 2644967
- Subsidy: $106.88
- Measure / Qty: per 30
Information for people who take this medicine
Pharmacies will have dispensed Teevir brand to you over recent months, while your usual brand of this medicine is unavailable. Stock of Teevir is likely to run out in June 2026.
Mylan brand funded
Pharmac has funded another brand, Tenofovir Efavirenz Emtricitabine (Mylan), to make sure you can continue to access treatment.
Same ingredients, same effect
Mylan brand has the same ingredients in the same quantities as Teevir. It is made in the same factory as Teevir. It is designed to work the same way as Teevir and Viatris brands.
Not Medsafe approved
Like Teevir, Medsafe has not reviewed this medicine so it is not approved for use in New Zealand. However, it is approved in other countries. The label is in English and French.
Your prescriber will tell you what this means before they prescribe it. You can read more information about unapproved medicine on the Healthify website.
Unapproved medicines | Healthify.nz(external link)
Information for pharmacists
Teevir (Pharmacode: 2705508) is likely to run out at the supplier by the end of June. This is the currently listed alternative brand for Viatris.
New alternative listed 12 June
We have listed a new alternative Mylan brand (Pharmacode: 2732041). It is funded from 12 June and has the same subsidy and measure. It is not approved so must still be prescribed and dispensed in line with section 29A of the Medicines Act.
The listing for Mylan should show in your dispensing software from 12 June. However, the listing will not show on the Online Schedule until it's updated for 1 July.
Do not order Teevir (India)
You may have noticed a Teevir (India) listing (Pharmacode: 2727994). This product is not available in New Zealand at this stage. Please make sure you order the Mylan brand.
Claiming
The Sector Operations Group will be able to process claims for June dispensing of the above listings.
Flyer for patients about unapproved medicines
- Unapproved Medicine flier A5 [PDF 131 KB]
Prescribing and supplying an unapproved medicine
Section 29A of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people.
We know supplying an unapproved medicine. In this case, however, this will allow people to continue to access an appropriate treatment.
We apologise for any inconvenience this causes.
Prescriber and pharmacist requirements for section 29 medicines – Medsafe website(external link)
What patients need to know about unapproved medicines – Healthify website(external link)
Expected resupply
We are working with Viatris to understand when this product will be available again.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)